leucovorin

FDA
Pharma

FDA approves leucovorin without clinical trial—but not for autism

The FDA has used real-world data to approve leucovorin to treat cerebral folate deficiency in patients who have a confirmed variant in the FOLR1 gene.
Angus Liu , Darren Incorvaia Mar 10, 2026 9:00am
Graphic image of a red thumbs down against a blue background

Pediatrician group declines to back leucovorin for autism

Oct 31, 2025 11:59am